MedDataX Logo

MAPS PrEP Van Study

NCT ID: NCT06908252

Last Updated: 2026-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-17

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings

NCT03651453

HIV Infections Substance Abuse
COMPLETED NA

Pre-exposure Prophylaxis (PrEP) Rapid Access

NCT05528562

Drug Use Pre-exposure Prophylaxis (PrEP) Opioid Use Disorder
COMPLETED NA

Pre-exposure Prophylaxis (PrEP) for Health

NCT04430257

Substance Dependence HIV (Human Immunodeficiency Virus)
RECRUITING NA

Pre-exposure Prophylaxis (PrEP) for People Who Inject Drugs (PWID)

NCT03869671

Intravenous Drug Abuse
WITHDRAWN NA

Packaging PrEP to Prevent HIV Among WWID

NCT03304912

HIV/AIDS
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to evaluate a pilot program that provides Pre-Exposure Prophylaxis (PrEP) for people who use drugs (PWUD) and are at risk for contracting HIV. Given the ongoing overdose crisis and the risk of HIV among PWUD, this study aims to assess weather offering oral PrEP on a Medical Mobile Unit (MMU) is a viable strategy for preventing HIV transmission in high-risk populations. The other goal of this study is to assess community perceptions of PrEP and perceived HIV risk among Syringe Service Program (SSP) clients visiting a MMU.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PrEP

All eligible participants will be given oral PrEP pills to reduce their risk for contracting HIV.

Group Type EXPERIMENTAL

Pre-Exposure Prophylaxis (PrEP)

Intervention Type DRUG

Oral Pre-Exposure Prophylaxis (PrEP) pills

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pre-Exposure Prophylaxis (PrEP)

Oral Pre-Exposure Prophylaxis (PrEP) pills

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older, active drug injection user and/or sexually active, referred from the Syringe Service Program

Exclusion Criteria

* positive HIV status
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

Sponsor Role collaborator

Duke University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mehri McKellar, MD

Role: PRINCIPAL_INVESTIGATOR

Duke Health

Jacqueline Hodges, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Duke Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Duke Department of Population Health Sciences

Durham, North Carolina, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amelia R Ashkin-Baker, BA

Role: CONTACT

[email protected]
(919)448-8680

Madelene Travis, BA

Role: CONTACT

[email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jacqueline Hodges, MD, MPH

Role: primary

[email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5P30AI064518-20

Identifier Type: NIH

Identifier Source: secondary_id

View Link

Pro00116108

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PrEP Intervention for People Who Inject Substances and Use Methamphetamine
NCT04523519 RECRUITING PHASE4
Adaptive Intervention Strategies for HIV PrEP Care in Rural People Who Inject Drugs
NCT06666309 ENROLLING_BY_INVITATION NA
An Intervention to Improve HIV Pre-exposure Prophylaxis Initiation, Adherence and Linkage to Care for Recently Incarcerated Men Who Inject Drugs.
NCT06316089 NOT_YET_RECRUITING NA
PrEP at a Syringe Services Program
NCT04782180 COMPLETED PHASE4
Likely Use of PrEP for African American YMSM
NCT02810249 COMPLETED
Pepped on Pre-exposure Prophylaxis (PrEP): A Counseling and Problem-Solving PrEP Adherence Intervention for Stimulant Using Men Who Have Sex With Men (MSM).
NCT03137342 COMPLETED NA
Expanding PrEP By Embedding Unannounced SNAPS Navigators in High STI Testing Clinical Sites
NCT04207151 COMPLETED NA
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
NCT01772823 COMPLETED PHASE2
PC4PrEP: Integrating PrEP Into Primary Care
NCT03617874 COMPLETED NA
Peer Outreach and Navigation Intervention to Increase PrEP Uptake Among Women at High Risk for HIV
NCT03226873 COMPLETED NA
Supporting Tailored And Responsive PrEP in Rural North Carolina
NCT05984030 COMPLETED NA
Periconception PrEP for HIV-exposed Ugandan Women
NCT03832530 COMPLETED NA
PrEP and Alcohol - Enhancing HIV Pre-Exposure Prophylaxis (PrEP)
NCT05097430 COMPLETED NA
Accelerated PrEP Access for Black MSM and TW
NCT04329442 WITHDRAWN NA
Testing an Integrated Bio-Behavioral Primary HIV Prevention Intervention Among High-Risk People Who Use Drugs
NCT03282890 COMPLETED NA
Pre-Exposure Prophylaxis in YMSM
NCT01033942 COMPLETED PHASE2
Prevention and Risk: Treatment With a New Emphasis on Relationships
NCT03396367 COMPLETED NA
Welcome to PrEP School Utilizing Peer Educators to Improve Uptake of Preexposure Prophylaxis for HIV at an HBCU
NCT07053527 NOT_YET_RECRUITING NA
PrEP for Prevention of HIV Transmission Among People Who Inject Drugs in Nairobi, Kenya
NCT05465265 COMPLETED NA
Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky
NCT05037513 COMPLETED NA
PrEP Talk: PrEP Uptake With Young Black MSM and Their Close Friends
NCT04601649 UNKNOWN EARLY_PHASE1
Clinical Decision Support for PrEP
NCT05245201 ACTIVE_NOT_RECRUITING NA
PrEP SMART Phase I Trial
NCT02895893 COMPLETED PHASE1
Uptake and Adherence to Daily Oral PrEP as a Primary Prevention Strategy for Young African Women: A Vanguard Study
NCT02732730 COMPLETED PHASE4
Integrating PrEP Into Family Planning Services at Title X Clinics in the Southeastern US
NCT04097834 COMPLETED